- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | - | - |
| R2 | - | - |
| R3 | - | - |
| PP | - | - |
| S1 | - | - |
| S2 | - | - |
| S3 | - | - |
Ratios
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE | 4.82 | - | 5.54 | - | 4.8 |
| ROE | 2.14 | - | 1.55 | - | 0.87 |
| EPS | 0.46 | 0.16 | 0.19 | 0.11 | 0.01 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|---|---|---|---|---|
| No data available | |||||
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
No data available
About Concord Drugs Ltd
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets.
The principal activity of the Company is to manufacture licensed drugs based o...
ISIN :INE858L01010
Registered Office
Survey No 249 Brahmanapally V,Hayathnagar M
Contact number
+ 91-40-24036379
Registrars
Aarthi Consultants Pvt Ltd
1-2-285 Domalguda Hyderabad - 500 029
1-2-285 Domalguda Hyderabad - 500 029
Contact number
+ 91-040-27638111/4445
Management
S Nagi Reddy (Chairman)
Open IPO’s
Price Range
₹461 - ₹485
Min. Quantity
30 Shares
Min. investment
₹14,550
Closes on
July 27, 2026
Price Range
₹404 - ₹425
Min. Quantity
35 Shares
Min. investment
₹14,875
Closes on
July 27, 2026
Price Range
₹120 - ₹127
Min. Quantity
110 Shares
Min. investment
₹13,970
Closes on
July 27, 2026
Price Range
₹151 - ₹152
Min. Quantity
95 Shares
Min. investment
₹14,440
Closes on
July 24, 2026
Price Range
₹72 - ₹77
Min. Quantity
3,200 Shares
Min. investment
₹2,46,400
Closes on
July 23, 2026
FAQs
The share price of Concord Drugs Ltd on the BSE is - as on -